Geratherm Medical AG (XTER:GME) LT-Debt-to-Total-Asset : 0.21 (As of Jun. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Geratherm Medical AG LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Geratherm Medical AG's long-term debt to total assests ratio for the quarter that ended in Jun. 2023 was 0.21.

Geratherm Medical AG's long-term debt to total assets ratio increased from Mar. 2022 (0.17) to Jun. 2023 (0.21). It may suggest that Geratherm Medical AG is progressively becoming more dependent on debt to grow their business.

Geratherm Medical AG LT-Debt-to-Total-Asset Historical Data

The historical data trend for Geratherm Medical AG's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Geratherm Medical AG LT-Debt-to-Total-Asset Chart

Geratherm Medical AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.08

0.16

0.19

0.26

0.24

Geratherm Medical AG Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.17	0.14	0.15	0.24	0.21

Geratherm Medical AG LT-Debt-to-Total-Asset Calculation

Geratherm Medical AG's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

LT Debt to Total Assets (A: Dec. 2022 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2022 )	/	Total Assets (A: Dec. 2022 )
	=	9.295	/	38.38
	=	0.24

Geratherm Medical AG's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jun. 2023 is calculated as

LT Debt to Total Assets (Q: Jun. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Jun. 2023 )	/	Total Assets (Q: Jun. 2023 )
	=	8.15	/	38.219
	=

Geratherm Medical AG (XTER:GME) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Geratherm Medical AG LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Geratherm Medical AG's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Geratherm Medical AG (XTER:GME) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Geratherm Medical AG (XTER:GME) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

GME:Germany

Address

Fahrenheitstrasse 1, Geratal, DEU, 99331

Website

https://www.geratherm.com

Geratherm Medical AG is a Germany-based medical technology company. The firm operates through four segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Healthcare Diagnostic segment which generates majority revenue provides analog and digital products for measuring body temperature, blood pressure monitors and other products for measuring temperature, as well as related accessories. Medical Warming Systems offers solutions for temperature management at all stages in the pre-clinical and clinical care of the patients, such as rescue situations and operations. Cardio/Stroke segment comprises products for preventing strokes. The Respiratory segment focuses on the development and production of products for pulmonary functional diagnostics.

Executives